A Feasibility and Safety Study of CD19 and CD22 Chimeric Antigen Receptors-Modified T Cell Cocktail for Therapy of B Cell Acute Lymphoblastic Leukemia

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Yang Junfang; Li Jianqiang; Zhang Xian; Lv Fanyong; Guo Xiaoling; Wang Qinglong; Wang Lin; Chen Dandan; Zhou Xiaosu; Ren Jinhai; Lu Peihua;

  展开▼
• 作者单位

  Hebei Yanda Lu Daopei Hosp Hematol &

  Immunotherapy Dept Langfang Peoples R China;

  Hebei Senlang Biotechnol Shijiazhuang Hebei Peoples R China;

  Hebei Yanda Lu Daopei Hosp Hematol &

  Immunotherapy Dept Langfang Peoples R China;

  Hebei Yanda Lu Daopei Hosp Langfang Peoples R China;

  Hebei Med Univ Hosp 2 Shijiazhuang Hebei Peoples R China;

  Hebei Senlang Biotechnol Shijiazhuang Hebei Peoples R China;

  Hebei Senlang Biotechnol Shijiazhuang Hebei Peoples R China;

  Hebei Senlang Biotechnol Shijiazhuang Hebei Peoples R China;

  Hebei Yanda Lu Daopei Hosp Langfang Peoples R China;

  Hebei Senlang Biotechnol Shijiazhuang Hebei Peoples R China;

  Hebei Yanda Lu Daopei Hosp Hematol &

  Immunotherapy Dept Langfang Peoples R China;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词